Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.44 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20563823 | 1.00 | CYP1A2 (0.56) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL28958757 | 0.90 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL4590669 | 0.90 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL4589554 | 0.90 | CYP1A2 (0.68) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL528806 | 0.83 | SMN1; SMN2 (0.51) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL11489425 | 0.81 | PTGS2 (0.55) | PTGS2KDM4EGRIA4LMNAGAA | |
| SCHEMBL12327023 | 0.81 | LMNA (0.59) | CYP1A2SMN1; SMN2NPSR1PTGS2LMNA | |
| SCHEMBL3468423 | 0.80 | ALOX5 (0.47) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL29213688 | 0.80 | ALOX5 (0.47) | CYP1A2SMN1; SMN2PKMCYP2D6NPSR1 | |
| SCHEMBL10885505 | 0.78 | PTGS2 (0.47) | CYP1A2SMN1; SMN2PKMPTGS2GRIA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | claimed |
| EP-4724418-A1 | TRICINE AND CITRIC ACID-BASED CATIONIC LIPIDS | Sanofi (FR) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025151874-A1 | INDOLE ALKALOID ANTIPLASMODIAL AGENTS AND PREPARATION THEREOF | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025104706-A2 | SMALL MOLECULE MODULATORS OF MAS AND MRGD RECEPTORS | XITRA THERAPEUTICS GMBH (DE) | 2025-05-22 | — | — | WO | disclosed |
| EP-4554671-A1 | CYCLIC PEPTIDE INHIBITORS OF IL-23 | JANSSEN Pharmaceutica NV (BE) | 2025-05-21 | — | — | EP | disclosed |
| EP-4486336-A2 | CB1 LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2025003759-A1 | DIANHYDROHEXITOL BASED IONIZABLE LIPIDS FOR NUCLEIC ACID DELIVERY | SANOFI (FR) | 2025-01-02 | — | — | WO | disclosed |
| EP-4475837-A2 | TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | Adarx Pharmaceuticals, Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| WO-2024148274-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| EP-4340859-A1 | ANTIBODY DRUG CONJUGATES USING MATES TECHNOLOGY FOR DELIVERING CYTOTOXIC AGENTS | Biohaven Therapeutics Ltd. (US) | 2024-03-27 | — | — | EP | disclosed |
| WO-2008013427-A1 | ORGANIC TFTS AND METHOD FOR FABRICATING THE SAME | LG CHEM, LTD. (KR) | 2008-01-31 | — | — | WO | disclosed |
| EP-1727801-A1 | PIPERAZINES USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2006-12-06 | — | — | EP | disclosed |
| EP-1664041-A1 | PHENYL-CARBOXAMIDE COMPOUNDS USEFUL FOR TREATING PAIN | Euro-Celtique S.A. (LU) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005066130-A1 | PIPERAZINES USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005035500-A2 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005030766-A1 | PHENYL - CARBOXAMIDE COMPOUNDS USEFUL FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 2005-04-07 | — | — | WO | disclosed |
| EP-0783519-A1 | NEW PEPTIDES WITH IMMUNOMODULATORY EFFECTS | Astra Aktiebolag (SE) | 1997-07-16 | — | — | EP | disclosed |
| WO-1996011943-A1 | NEW PEPTIDES WITH IMMUNOMODULATORY EFFECTS | ASTRA AKTIEBOLAG (SE) | 1996-04-25 | — | — | WO | disclosed |
| EP-0651761-A1 | METHOD FOR MODIFICATION OF RECOMBINANT POLYPEPTIDES | BIONEBRASKA, INC. (US) | 1995-05-10 | — | — | EP | disclosed |
| WO-1994001451-A2 | METHOD FOR MODIFICATION OF RECOMBINANT POLYPEPTIDES | BIONEBRASKA, INC. (US) | 1994-01-20 | — | — | WO | disclosed |